Phosphoric Acid — predicted protein targets

Known targets — ChEMBL curated mechanism

ADRA1A ADRA1B ADRA1D ADRB1 ADRB2 ADRB3 CYP11B1 DPP4 FGFR1 FGFR2 FGFR3 FGFR4 HRH1 JAK1 JAK2 JAK3 KCNA1 KCNA10 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 KCNB1 KCNB2 KCNC1 KCNC2 KCNC3 KCNC4 KCND1 KCND2 KCND3 KCNF1 KCNG1 KCNG2 KCNG3 KCNG4 KCNH1 KCNH2 KCNH3 KCNH4 KCNH5 KCNH6 KCNH7 KCNH8 KCNQ1 KCNQ2 KCNQ3 KCNQ4 KCNQ5 KCNS1 KCNS2 KCNS3 KCNV1 KCNV2 KDR KIT NA OPRD1 OPRK1 OPRM1 P PDGFRB PIK3CD SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SMO TYK2 pol rplA rplB rplC rplD rplE rplF rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmC rpmD rpmE rpmF rpmG rpmH rpmI rpmJ rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsS rpsT rpsU ykgM ykgO

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	MEN1	O00255	2/20	0.44

▸	CYP3A4	P08684	2/20	0.44

▸	ALOX15	P16050	2/20	0.44

▸	KMT2A	Q03164	2/20	0.44

▸	MAPT	P10636	2/20	0.42

▸	ALDH1A1	P00352	1/20	0.42

▸	UGT1A1	P22309	1/20	0.42

▸	BTN3A1	O00481	3/20	0.41

▸	GGPS1	O95749	8/20	0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Phosphoric Acid SCHEMBL10336339	1.00	MEN1 (0.44)	MEN1CYP3A4ALOX15KMT2AMAPT
Pyrophosphoric Acid SCHEMBL7743852	0.85	BTN3A1 (0.55)	MEN1CYP3A4ALOX15KMT2AMAPT
SCHEMBL115620	0.84	—	—
SCHEMBL8813968	0.84	KMT2A (0.55)	MEN1CYP3A4ALOX15KMT2AMAPT
Formaldehyde SCHEMBL8208771	0.81	—	—
Bromide SCHEMBL9843003	0.81	—	—
Hydrogen Peroxide SCHEMBL31511442	0.81	—	—
Geraniol SCHEMBL20481327	0.79	KMT2A (0.79)	MEN1CYP3A4ALOX15KMT2AMAPT
Geraniol SCHEMBL20481326	0.79	KMT2A (0.79)	MEN1CYP3A4ALOX15KMT2AMAPT
Geraniol SCHEMBL27699074	0.79	KMT2A (0.79)	MEN1CYP3A4ALOX15KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20080318227-A1	Intermediates and enzymes of the non-mevalonate isoprenoid pathway	BACHER ADELBERT	2008-12-25	—	—	US	disclosed
US-20080300222-A1	Phosphoantigen Salts Of Organic Bases And Methods For Their Crystallization	INNATE PHARMA (FR)	2008-12-04	—	—	US	disclosed
EP-1933848-A2	PHOSPHOANTIGEN SALTS OF ORGANIC BASES AND METHODS FOR THEIR CRYSTALLIZATION	Innate Pharma (FR)	2008-06-25	—	—	EP	disclosed
US-7297509-B2	Intermediates and enzymes of the non-mevalonate isoprenoid pathway	Bacher, Adelbert (DE)	2007-11-20	—	—	US	disclosed
WO-2007039635-A2	PHOSPHOANTIGEN SALTS OF ORGANIC BASES AND METHODS FOR THEIR CRYSTALLIZATION	INNATE PHARMA (FR)	2007-04-12	—	—	WO	disclosed
US-20040176570-A1	Intermediates and enzymes of the non-mevalonate isoprenoid pathway	ROHDICH, FELIX (DE)	2004-09-09	—	—	US	disclosed
EP-1377663-A2	INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY	Bacher, Adelbert (DE)	2004-01-07	—	—	EP	disclosed
WO-2002083720-A2	INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY	BACHER ADELBERT (DE)	2002-10-24	—	—	WO	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20040176570-A1	Intermediates and enzymes of the non-mevalonate isoprenoid pathway	FDPS, DHPS, COASY	MEN1 1622/4885CYP3A4 244/4885ALOX15 2054/4885
US-20080300222-A1	Phosphoantigen Salts Of Organic Bases And Methods For Their Crystallization	HLA-B, LCK, HLA-A	MEN1 3785/4885CYP3A4 4004/4885ALOX15 1720/4885
US-20080318227-A1	Intermediates and enzymes of the non-mevalonate isoprenoid pathway	FDPS, DHPS, COASY	MEN1 1731/4885CYP3A4 311/4885ALOX15 1870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.